Je confirme être un professionnel de santé*

Valider

* Conformément à la loi française de décembre 2011 relative au renforcement de la sécurité sanitaire et à ses décrets d'application de mai 2012, « les sections des sites internet réservées aux seuls professionnels de santé doivent être, à minima, accessibles après une page d'engagement de l'internaute, certifiant qu'il est un professionnel de santé. »

Informations sur les cookies

Les cookies sont des petits fichiers installés sur votre ordinateur ou votre smartphone. Ils nous permettent de stocker des informations relatives à votre navigation sur notre site.

En savoir plus Accepter les cookies

Politique de confidentialité

Accepter les cookies Fermer

Informations sur les cookies

Olea Medical utilise trois types de cookies :

  • Les cookies de session ou de préférences qui sont indispensables à la navigation et au bon fonctionnement du site
  • Les cookies de mesure d’audience et autres traceurs servant à établir les statistiques d’audience du site

Ces cookies sont paramétrés selon les critères d’exemption du consentement tels que définis par la CNIL

Nom du cookieTypeDescription
Nécessaire à la fourniture du serviceMémorise l'attestation obligatoire "professionnel de santé"
Nécessaire à la fourniture du serviceStocke le consentement pour chaque cookie de type “traceur”.
Nécessaire à la fourniture du serviceStocke l'authentification nécessaire au téléchargement des cases reports
Authentification clientEspace client uniquement. Ce cookie ne sera pas installé si vous ne vous connectez pas à votre compte.
Authentification clientEspace client uniquement. Ce cookie ne sera pas installé si vous ne vous connectez pas à votre compte.
Authentification clientEspace client uniquement. Ce cookie ne sera pas installé si vous ne vous connectez pas à votre compte.
Authentification clientEspace client uniquement. Ce cookie ne sera pas installé si vous ne vous connectez pas à votre compte.
Authentification clientEspace client uniquement. Ce cookie ne sera pas installé si vous ne vous connectez pas à votre compte.
Authentification clientEspace client uniquement. Ce cookie ne sera pas installé si vous ne vous connectez pas à votre compte.
Nécessaire à la fourniture du serviceStocke la langue courante
Mesure d'audienceGoogle analytics
Mesure d'audienceGoogle analytics
Mesure d'audienceGoogle analytics
Nécessaire à la fourniture du serviceAssocié aux services CloudFlare concernant la sécurité du site

Publications scientifiques

Determinants of CT Perfusion Misrepresentation of Ischemic Core in Endovascular Stroke Therapy.

Rosenbaum-Halevi D, Vahidy FS, Daileda T, Chen PR, Yoo AJ, Liang CW, Savitz SI, Sheth SA. Determinants of CT Perfusion Misrepresentation of Ischemic Core in Endovascular Stroke Therapy. ISC- International Stroke Conference. January 2018. Los Angeles (USA).
Voir

Usefulness of non-contrast CT ASPECTS in the penumbra in predicting functional outcome after IV thrombolysis.

Domenech-Ximenos B, Cuba V, Blasco G, Daunis-i-Estadella P, Biarnes C, Martí-Navas M, Alberich-Bayarri A, Thio-Henestrosa S, Serena J, Terceño M, Silva Y, Essig M, Nael K, Leiva-Salinas C, Wintermark M, Pedraza S, Puig J. Usefulness of non-contrast CT ASPECTS in the penumbra in predicting functional outcome after IV thrombolysis. ASNR. June 2018. Vancouver (Canada).
Voir

Intérêt d’une analyse volumique de la perfusion en IRM dans le diagnostic de pseudoprogression lors du suivi des glioblastomes traités par radio-chimiothérapie concomitantes.

Roques M, Catalaa I, Attal J, Ferrier M, Patsoura S, Gramada R, de Champfleur NM, Cognard C, Bonneville, F. (2018). Intérêt d’une analyse volumique de la perfusion en IRM dans le diagnostic de pseudoprogression lors du suivi des glioblastomes traités par radio-chimiothérapie concomitantes. SFNR. 2018. Paris (France).
Voir

Prospective Evaluation of Blood-Brain-Barrier Integrity and Cerebrospinal Fluid Lipocalin-2 Protein Levels in Aneurysmal Subarachnoid Hemorrhage: Correlation with Disease Severity.

Ivanidze J, Ferraro R, Segal A Gupta A; Sanelli PC. Prospective Evaluation of Blood-Brain-Barrier Integrity and Cerebrospinal Fluid Lipocalin-2 Protein Levels in Aneurysmal Subarachnoid Hemorrhage: Correlation with Disease Severity. ASNR. June 2018. Vancouver (Canada).
Voir

Accuracy of dynamic contrast-enhanced derived quantitative parameters in diagnosing prostate cancer using whole-mount histology after radical prostatectomy as a reference.

Greco F, Zuiani C, De Stefano M, Cereser L, Como G, Girometti R. Accuracy of dynamic contrast-enhanced derived quantitative parameters in diagnosing prostate cancer using whole-mount histology after radical prostatectomy as a reference. ECR. 2018. Vienna (Austria).
Voir

T2-mapping of the trapezio-metacarpal joint and triangular fibrocartilage complex: a feasibility and reproducibility study.

Albano D, Chianca V, Cuocolo R, Messina C, Gabriele M, Iodice M, Ricci D, Lazzara A, Biacca A, Brunetti A, Sconfienza LM. T2-mapping of the trapezio-metacarpal joint and triangular fibrocartilage complex: a feasibility and reproducibility study. ESSR. June 2018. Amsterdam (Netherlands)
Voir

Core Growth Speed as a Marker of Collateral Circulation Status in Acute Ischemic Stroke with Known Onset Time.

Blanco-García L, Cortijo E, De Lera M, Calleja A, Usero M, Castaño M, Pérez-Fernández S, Arenillas J. Core Growth Speed as a Marker of Collateral Circulation Status in Acute Ischemic Stroke with Known Onset Time. ISC. 2017. Houston (USA).
Voir

Multiparametric CT Perfusion to Determine the Collaterals Status in Patients With Acute Ischemic Stroke: A New Perfusion Index.

Awad AJ, Wei D, Haroun RR, Oxley TJ, Fifi JT, Doshi AH, De Leacy RA, BedersonJB, Mocco J, Nael K. Multiparametric CT Perfusion to Determine the Collaterals Status in Patients With Acute Ischemic Stroke: A New Perfusion Index. ECR. 2017. Vienna (Austria).
Voir

Comparison of Two Methods of the Alberta Stroke Program Early CT Score.

Linn AJ, O'Donnell S, de Havenon A. Comparison of Two Methods of the Alberta Stroke Program Early CT Score. ISC. 2017. Houston (USA).
Voir

A Simple Tool to Predict Target Mismatch in Ischemic Stroke Patients with Anterior Circulation Occlusion.

de Havenon A, O’Donnell S, Linn A, McNally S, Dunleavy B, Majersik J. A Simple Tool to Predict Target Mismatch in Ischemic Stroke Patients with Anterior Circulation Occlusion. ISC. 2017. Houston (USA).
Voir

Computed Tomography Angiography is Better at Predicting Lesion Core Volume in Acute Ischemic Stroke Patients with Proximal Occlusion.

O’Donnell S, Linn A, Majersik J, Wang H, Chung L, de Havenon A. Computed Tomography Angiography is Better at Predicting Lesion Core Volume in Acute Ischemic Stroke Patients with Proximal Occlusion. ISC. 2017. Houston (USA).
Voir

Etude de la perfusion myocardique et évaluation de nouvelles approches de quantification bayésiennes et spatio-temporelles.

Daviller C, Giacalone M, Frindel C, Boutelier T, Croisille P, Viallon M. Etude de la perfusion myocardique et évaluation de nouvelles approches de quantification bayésiennes et spatio-temporelles. 3ème Congrès de la SFRMBM, 2017. Bordeaux (France) .
Voir

Multiparametric MRI margin characterization for focal brachytherapy in low-grade prostate cancer.

Ken S, Arnaud F, Aziza R, Portalez D, Malavaud B, Bachaud J, Graff-Cailleaud P, Lusque A, Brun T. Multiparametric MRI margin characterization for focal brachytherapy in low-grade prostate cancer.  ESTRO. 2017. Vienna (Austria).
Voir

Correlation Between IDH Mutation Status, Patient Survival, and Blood Volume Estimates in Diffuse Gliomas: a TCGA/TCIA Project.

Littig I, Poisson L, Patel S, Nunes L, Chi A, Jain R. Correlation Between IDH Mutation Status, Patient Survival, and Blood Volume Estimates in Diffuse Gliomas: a TCGA/TCIA Project. ASNR. 2017. Long Beach (USA).
Voir

Semi-Automated Assessment for Distinguishing Glioblastoma and Solitary Brain Metastasis: A Machine Learning Approach.

Swinburne N, Schefflein J, Sakai Y, Chen I, Doshi A, Puig J, Nael K. Semi-Automated Assessment for Distinguishing Glioblastoma and Solitary Brain Metastasis: A Machine Learning Approach. ASNR. 2017. Long Beach (USA).
Voir

Brain MRI Findings Which May Predict Progression of Mild Cognitive Impairment.

Peters E, Uyoyo U, Kido D, Achiriloaie A. Brain MRI Findings Which May Predict Progression of Mild Cognitive Impairment. AAIC. 2017. London (UK).
Voir

Physical activity during childhood positively affects structural brain connectivity in adulthood.

Blasco G, Biarnés C, Rivero M, Puig-Parnau M, Roman-Viñas B, Font R, Prats-Puig A, Gich J, Ramió-Torrentà L, Pedraza S, Puig J. Physical activity during childhood positively affects structural brain connectivity in adulthood. ASNR. 2017. Long Beach (USA).
Voir

Multiparametric CT Perfusion to Determine the Collaterals Status in Patients With Acute Ischemic Stroke: A New Perfusion Index.

Awad AJ, Rigney B, Wei D, Oxley T, Puig J, Fifi J, Doshi A, DeLeacy R, Bederson JB, Mocco J, Nael K. Multiparametric CT Perfusion to Determine the Collaterals Status in Patients With Acute Ischemic Stroke: A New Perfusion Index. ASNR. 2017. Long Beach (USA).
Voir

A simple prognostic tool for predicting 3-month functional outcome 24 hours after ischemic stroke.

Puig J, Hernández-Pérez M, Thio-Henestrosa S, Blasco G, Daunis-i-Estadella P, Biarnés C, Serena J, Castellanos M, Terceño M, Silva Y, Martí M, Nael K, Wintermark M, Pedraza S. A simple prognostic tool for predicting 3-month functional outcome 24 hours after ischemic stroke. ASNR. 2017. Long Beach (USA).
Voir

Comparaison des volumes calculés en IRM par RAPID et Olea Sphere au cours d’accidents ischémiques aigus: une étude retrospective et comparative.

Darcourt J, Michelozzi C, Januel AC, Guenegot A, Vukasinovic I, Scudeler M, Tall P, Bonneville F, Cognard C. Comparaison des volumes calculés en IRM par RAPID et Olea Sphere au cours d’accidents ischémiques aigus: une étude retrospective et comparative. JFR. 2017. Paris (France).
Voir

Evaluation de Méthodes de Quantification de la Perfusion Cardiaque : Approches Bayésiennes et Spatio-temporelle. Recherche en Imagerie et Technologies pour la Santé (RITS).

Daviller C, Giacalone M, Frindel C, Boutelier T, Croisille P, Viallon M. Evaluation de Méthodes de Quantification de la Perfusion Cardiaque : Approches Bayésiennes et Spatio-temporelle. Recherche en Imagerie et Technologies pour la Santé (RITS). Mar 2017. Lyon (France)
Voir

Diagnostic Value of Calculated High B Value DWI for Prostate Cancer Detection.

Wagner M, Corcuera I, Kang M, Hectors S, Rastinehad A, Chaibi Y, Taouli B. Diagnostic Value of Calculated High B Value DWI for Prostate Cancer Detection. ISMRM. 2017. Honolulu (USA).
Voir

Glioblastoma: the importance of MRI and radiogenomics in patient management.

Gimeno A, Blasco G, Biarnés C, Martí M, Alberich-Bayarri A, Puigdemont M, Wintermark M, Nael K, Essig M, Pedraza S, Jain R, Puig J. Glioblastoma: the importance of MRI and radiogenomics in patient management. ASNR. 2017. Long Beach (USA).
Voir

Does IntraVoxel Incoherent Motion (IVIM) MP-MRI have a role in the detection and stratification of prostate cancer?

Pesapane F, Patella F, Panella S, Zanchetta E, Fumarola E, Franceschelli G, Pompili G, Carrafiello G, Sardanelli F. Does IntraVoxel Incoherent Motion (IVIM) MP-MRI have a role in the detection and stratification of prostate cancer? ECR. 2017. Vienna (Austria) C-0437.
Voir

Diminution transitoire de la connectivité fonctionnelle interhémisphérique entre régions homologues en postopératoire immédiat d’une chirurgie éveillée chez des patients porteurs de lésions gliales.

Coget A, Deverdun J, Le Bars E, van Dokkum L, Molino F, de Champfleur NM. Diminution transitoire de la connectivité fonctionnelle interhémisphérique entre régions homologues en postopératoire immédiat d’une chirurgie éveillée chez des patients porteurs de lésions gliales. Journal of Neuroradiology. 2017; 44(2):75-76. Paris (France).
Voir

Is multiparametric MRI able to characterize margin for focal brachytherapy in low-grade prostate cancer?

Ken S, Graff-Cailleaud P, Bachaud JM, Aziza R, Arnault S, Lusque A, Arnaud FX, Brun T, Portalez D, Malavaud B. (2017). Is multiparametric MRI able to characterize margin for focal brachytherapy in low-grade prostate cancer? Journal of Clinical Oncology. 2017 Feb; 35(6_suppl):e555.
Voir

Brain MRI Findings Which may predict progression of mild cognitive impairment.

Peters EM, Uyoyo U, Kido D, Achiriloaie A. Brain MRI Findings Which may predict progression of mild cognitive impairment. Alzheimer's & Dementia. 2017; 13(7):1103-1104. London (England)
Voir

Structural and functional brain connectivity biomarkers and cognitive impairment in multiple sclerosis.

Puig J, Blasco G, Biarnés C, Gich J, Rivero M, Salvedra J, Beltran B, Alberich-Bayarri A, Daunis-i-Estadella P, Thio-Henestrosa S, Wintermark M, Nael K, Pedraza S, Ramió-Torrentà L. Structural and functional brain connectivity biomarkers and cognitive impairment in multiple sclerosis. ASNR. 2017. Long Beach (USA).
Voir

Verbal memory impairment in multiple sclerosis and brain structural damage on diffusion tensor imaging.

Puig J, Blasco G, Biarnés C, Gich J, Rivero M, Salvedra J, Beltran B, Alberich-Bayarri A, Daunis-i-Estadella P, Thio-Henestrosa S, Wintermark M, Nael K, Pedraza S, Ramió-Torrentà L. Verbal memory impairment in multiple sclerosis and brain structural damage on diffusion tensor imaging. ASNR. 2017. Long Beach (USA).
Voir

Magnetic resonance pancreatic fat-fraction and volume: association with obesity.

Cuba V, Gimeno A, Perea M, Blasco G, Puig J, Daunis-i-Estadella J, Xifra G, Manuel Fernández-Real J, Salvador Pedraza S. Magnetic resonance pancreatic fat-fraction and volume: association with obesity. ECR. 2016. Vienna (Austria).
Voir

A Comparison of Automated and Manual Volumetric Analysis of CT Perfusion In Acute Ischemic Stroke.

Dunleavy B, Chung L, Majersik J, de Havenon A. A Comparison of Automated and Manual Volumetric Analysis of CT Perfusion In Acute Ischemic Stroke. ISC. 2016. Los Angeles (USA).
Voir

Prognostic Ability of Automated Versus Manual Volumetric Measurement of the Ischemic Stroke Core and Penumbra.

de Havenon A, Donleavy B, Wang H, Chung L, Majersik J. Prognostic Ability of Automated Versus Manual Volumetric Measurement of the Ischemic Stroke Core and Penumbra. ISC. 2016. Los Angeles (USA).
Voir

Collateral Scoring, Ischemic Penumbra, and Final Stroke Volume in Acute Ischemic Stroke.

O’Donnell S, Majersik JJ, Donleavy B, Chung L, Smith G, de Havenon A. Collateral Scoring, Ischemic Penumbra, and Final Stroke Volume in Acute Ischemic Stroke. AAN. 2016. Vancouver (Canada).
Voir

Prediction of Neurologic Outcome after Ischemic Stroke with Volumetric Measurements on CT and MRI.

de Havenon A, Donleavy B, Wang H, Chung L, Majersik J. Prediction of Neurologic Outcome after Ischemic Stroke with Volumetric Measurements on CT and MRI. Stroke. 2016. 47 (Suppl 1) - Poster form the International Stroke Conference (ISC).
Voir

Collaterals and the Severity of Hypoperfusion in Acute Ischemic Stroke are Independent of Dehydration or Volume Status.

Liebeskind DS, Woolf GW, Sanossian N, Liu D, Sheth SA, Liang CW, Ali LK, Kim D, Hinman JD, Rao NM, Starkman S, Jahan R, Gonzalez NR, Tateshima S, Duckwiler GR, Saver JL, Yoo B, Scalzo F. Collaterals and the Severity of Hypoperfusion in Acute Ischemic Stroke are Independent of Dehydration or Volume Status. ISC. 2016. Los Angeles (USA).
Voir

Effect of Phase Correction on DTI and q-space Metrics.

Pizzolato M, Boutelier T, Deriche R. Effect of Phase Correction on DTI and q-space Metrics. ISMRM workshop. 2016. Lisbon (Portugal).
Voir

Improved Vascular Transport Function Characterization in DSC-MRI via Deconvolution with Dispersion-Compliant Bases.

Pizzolato M, Fick R, Boutelier T, Deriche R. Improved Vascular Transport Function Characterization in DSC-MRI via Deconvolution with Dispersion-Compliant Bases. ISMRM. 2016. Singapore (Singapore).
Voir

Prostate Cancer Detection: Added Value of Calculated B2000.

Wagner M, Corcuera-Solano I, Lewis S, Kang M, Hectors S, Taouli B. Prostate Cancer Detection: Added Value of Calculated B2000. JFR. 2016. Paris (France).
Voir

Sequential MR Diffusion for Assessment of Tumor Progression in Follow up of Patients with Low Grade Glioma.

Nael K, Chen I,  Hefti M, Tsankova N, Doshi AH, Delman BN. Sequential MR Diffusion for Assessment of Tumor Progression in Follow up of Patients with Low Grade Glioma. RSNA. 2016. Chicago (USA).
Voir

Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a comparative study of pharmacokinetic models and correlation with mRECIST criteria.

Vivoda Tomši? M, Šurlan-Popovi? K, Bisdas S, Kova? V, Serša I. Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a comparative study of pharmacokinetic models and correlation with mRECIST criteria. ECR. 2016. Vienna (Austria). 
Voir

Diffusion tensor imaging shows brain structural damage associated with verbal memory in subjects with multiple sclerosis.

Ramió L, Blasco G, Biarnés C, Gich J, Rivero M, Salvedra J, Daunis-i-Estadella P, Pedraza S, Puig J. Diffusion tensor imaging shows brain structural damage associated with verbal memory in subjects with multiple sclerosis. ECTRIMS. 2016. London (UK). 
Voir

CT-Based Collateral Scoring Can Predict Ischemic Penumbra Volume in Acute Ischemic Stroke.

O’Donnell S, Majersik JJ, Donleavy B, Chung L, Smith G, de Havenon A. CT-Based Collateral Scoring Can Predict Ischemic Penumbra Volume in Acute Ischemic Stroke. ANN. 2016. Vancouver (Canada).
Voir

Perfusion CT indexes and derived blood-brain barrier permeability predicts hemorrhagic transformation risk after intravenous thrombolysis in acute stroke.

Carbo G, Cuba V, Puig J, Blasco G,  Daunis-i-Estadella J, Castellanos M, Van Eendenburg C, Aboud C, Pedraza S. Perfusion CT indexes and derived blood-brain barrier permeability predicts hemorrhagic transformation risk after intravenous thrombolysis in acute stroke. ECR. 2016. Vienna (Austria). 
Voir

Stratégies et résultats de la segmentation volumique lésionnelle de l’AVC en IRM.

Chaptal T, Le Bars E, Menjot de Champfleur N, Costalat V, Bonafé A. Stratégies et résultats de la segmentation volumique lésionnelle de l’AVC en IRM. SFNR. 2016. Paris (France).  Journal of Neuroradiology. March 2016. 43(2): 115–116.
Voir

Utility of diffusion and perfusion MRI for predicting perihemorrhagic edema growth after intracerebral haemorrhage.

Carbo G, Cuba V, Puig J, Blasco G,  Daunis-i-Estadella J, Terceño M, Silva Y, Serena, J Pedraza S. Utility of diffusion and perfusion MRI for predicting perihemorrhagic edema growth after intracerebral haemorrhage. ECR. 2016. Vienna (Austria). 
Voir

MR Perfusion to Determine the Status of Collaterals in Patients with Acute Ischemic Stroke: Look Beyond Perfusion Time-maps.

Nael K, Kintter J, Doshi A, Mocco J, Deleacy R, Bederson J, Naidich T. MR Perfusion to Determine the Status of Collaterals in Patients with Acute Ischemic Stroke: Look Beyond Perfusion Time-maps. ASNR. 2016. Washington (USA). 
Voir

Prediction of Thrombolysis-induced Parenchymal Hemorrhage in Patients With Acute Ischemic Stroke: Use of MR Perfusion and Diffusion Biomarkers.

Nael K, Knitter J, Jahan R,  Alger JR, Nenov V, et al. Prediction of Thrombolysis-induced Parenchymal Hemorrhage in Patients With Acute Ischemic Stroke: Use of MR Perfusion and Diffusion Biomarkers. ISC. 2016. Los Angeles (USA).
Voir

MR Perfusion to Determine the Status of Collaterals in Patients With Acute Ischemic Stroke: Look Beyond Perfusion Time-maps.

Nael K, Knitter J, Doshi A, Mocco J, Naidich T. MR Perfusion to Determine the Status of Collaterals in Patients With Acute Ischemic Stroke: Look Beyond Perfusion Time-maps. ISC. Los Angeles (USA).
Voir

Utility of diffusion and perfusion MRI for predicting perihemorrhagic edema growth after intracerebral hemorrhage.

Puig J, Blasco G, Daunis-i-Estadella J, Carbó G, Cuba V, Terceño M, Silva Y, van Eendenburg C, Serena J, Menon G, Wintermark M, Pedraza S. Utility of diffusion and perfusion MRI for predicting perihemorrhagic edema growth after intracerebral hemorrhage. ASNR. 2016. Washington (USA).
Voir

Predicting Motor Outcome in Acute Intracerebral Hemorrhage.

Puig J, Blasco G, Terceño M, Daunis-i-Estadella J, Hernández-Pérez M, Cuba V, Carbó G, Serena J, van Eendenburg C, Alberich-Bayarri A, Schlaug G, Menon B, Wintermark M, Silva Y, Pedraza S. Predicting Motor Outcome in Acute Intracerebral Hemorrhage. ASNR. 2016. Washington (USA).
Voir

COMBINING MOTOR FUNCTION AND DIFFUSION TENSOR IMAGING DERIVED MEASURES PREDICT MOTOR OUTCOME IN PATIENTS WITH ACUTE INTRACEREBRAL HEMORRHAGE.

Puig J, Blasco G, Terceño M, Serena J, Hernández-Pérez M, Daunis-i-Estadella P, Cuba V, Carbó G, Alberich-Bayarri A, Schlaug G, Menon B, Wintermark M, Pedraza S, Silva Y. COMBINING MOTOR FUNCTION AND DIFFUSION TENSOR IMAGING DERIVED MEASURES PREDICT MOTOR OUTCOME IN PATIENTS WITH ACUTE INTRACEREBRAL HEMORRHAGE. ESOC. 2016. Barcelona (Spain).
Voir

MR Perfusion to Determine the Status of Collaterals in Patients with Acute Ischemic Stroke: Look Beyond Perfusion Time-maps.

Nael K, Knitter JR, Doshi AH, Mocco J, Deleacy R, Bederso J. MR Perfusion to Determine the Status of Collaterals in Patients with Acute Ischemic Stroke: Look Beyond Perfusion Time-maps. RSNA. 2016. Chicago (USA).
Voir

Magnitude of contrast-enhancement of normal peripheral zone on 3.0T prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI): a study with different injection protocols using gadobenatedimeglumine (Gd-BOPTA).

Bednarova I, Zerial M, Cereser L, Zuiani C, Bazzocchi M, Girometti R. Magnitude of contrast-enhancement of normal peripheral zone on 3.0T prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI): a study with different injection protocols using gadobenatedimeglumine (Gd-BOPTA). ECR. 2016. Vienna (Austria).
Voir

Perfusione in risonanza magnetica nello studio di gliomi cerebrali: riproducibilita? e confronto di dati ottenuti utilizzando due software di analisi.

Conte GM, Iadanza A, Cadioli M, Castellano A, Falini A, Terreni MR, Franzin A, Calori G, Anzalone N. Perfusione in risonanza magnetica nello studio di gliomi cerebrali: riproducibilita? e confronto di dati ottenuti utilizzando due software di analisi. OSR. 2016. Milan (Italy).
Voir

Biomarkers for glioblastoma: MMP2 and NGAL.

Shehan J, Gupta S, Rachagani S, Zhang Y, Mallya K, Pai P, Kaur S, Jain M, Kueh A, White M, Aizenberg M, McComb R, Smith L, Batra S, Shonka N. Biomarkers for glioblastoma: MMP2 and NGAL. Journal of Clinical Oncology. 2016. 34(15_suppl): e13516
Voir

The correlation between quantitative parameters in multiparametric MRI and PI-RADS 2.0.

Jin B, Wei C, Szewczyk-Bieda M, Nabi G. The correlation between quantitative parameters in multiparametric MRI and PI-RADS 2.0. European Journal of Surgical Oncology. 2016; 42(11): 226-227. Liverpool (England).
Voir

Changes in brain signal intensity after intravenous injections of 0.075 mmol/kg of gadobenate dimeglumine: a retrospective evaluation of 112 patients.

Doniselli FM, Sdao S, De Angelis C, Bandirali M, Papini GDE, Messina C, Casolino D, Di Leo G, Sardanelli F. Changes in brain signal intensity after intravenous injections of 0.075 mmol/kg of gadobenate dimeglumine: a retrospective evaluation of 112 patients. ECR. 2016. Vienna (Austria).
Voir

Exploiting the Phase in Diffusion MRI for Microstructure Recovery: Towards Axonal Tortuosity via Asymmetric Diffusion Processes.

Pizzolato M, Wassermann D, Boutelier T, Deriche R. Exploiting the Phase in Diffusion MRI for Microstructure Recovery: Towards Axonal Tortuosity via Asymmetric Diffusion Processes. MICCAI. 2015. Munich (Germany).
Voir

Reproducibility of dynamic contrast-enhanced MRI in oncology: 2D vs 3D approach.

Hibat Allah S, Wagner M, Raslan S, Lucidarme O. Reproducibility of dynamic contrast-enhanced MRI in oncology: 2D vs 3D approach. ECR. 2015. Vienna (Austria).
Voir

Differentiation of Solitary Brain Metastasis from Glioblastoma Multiforme: A Predictive Model Using Combined MR Diffusion and Perfusion.

Bauer A, William Erly, Marcel Maya, Moser F, Nael K.Differentiation of Solitary Brain Metastasis from Glioblastoma Multiforme: A Predictive Model Using Combined MR Diffusion and Perfusion. ASNR. 2015. Chicago (USA). 
Voir

THE IMPACT OF MRI PERFUSION IMAGING IN THE DIFFERENTIATION OF PROGRESSION AND PSEUDOPROGRESSION IN PATIENTS WITH GLIOBLASTOMA.

Purkart TU, Payer F, Bohlsen D, Fazekas F. THE IMPACT OF MRI PERFUSION IMAGING IN THE DIFFERENTIATION OF PROGRESSION AND PSEUDOPROGRESSION IN PATIENTS WITH GLIOBLASTOMA.  Society for Neuro-Oncology . 2015. San Antonio (USA).
Voir

Multiparametric MR Perfusion in Characterization of Parathyroid Adenomas.

Nael K, Hur S.H, Bauer A, Khan R, Guerrero M. Multiparametric MR Perfusion in Characterization of Parathyroid Adenomas. ASNR. 2015. Chicago (USA).
Voir

Comparison of oSVD-based Deconvolution Time to Maximum Residue Function (Tmax) and Bayesian-based Deconvolution Arterial Tissue Delay (ATD) for Determination of Ischemic Penumbra in Asymptomatic Patients With Cerebrovascular Occlusion.

Davis A, Boutelier T, Andrle A. Comparison of oSVD-based Deconvolution Time to Maximum Residue Function (Tmax) and Bayesian-based Deconvolution Arterial Tissue Delay (ATD) for Determination of Ischemic Penumbra in Asymptomatic Patients With Cerebrovascular Occlusion. ASNR. 2015. Chicago (USA).
Voir

Determination of CT Perfusion Thresholds for the Evaluation of Acute Ischemic Core and Penumbra Utilizing Bayesian Deconvolution Method.

Litao M, Davis A, Wake N, Babb J, Andrle A, Bucciarelli B, Hashimoto K, Mitulescu A, Chaibi Y. Determination of CT Perfusion Thresholds for the Evaluation of Acute Ischemic Core and Penumbra Utilizing Bayesian Deconvolution Method. ASNR. 2015. Chicago (USA).
Voir

Risk of Thrombolysis-induced Hemorrhagic Transformation in Patients with Acute Ischemic Stroke: A Predictive Model Using Combined MR Perfusion Biomarkers.

Nael K, Knitter J, Bauer A, Kidwell CS. Risk of Thrombolysis-induced Hemorrhagic Transformation in Patients with Acute Ischemic Stroke: A Predictive Model Using Combined MR Perfusion Biomarkers. SNR. 2015. Chicago (USA).
Voir

Risk of Thrombolysis-induced Hemorrhagic Transformation in Patients with Acute Ischemic Stroke: A Predictive Model Using Combined MR Perfusion Biomarkers.

Nael K, Bauer A, Kidwell C.S. Risk of Thrombolysis-induced Hemorrhagic Transformation in Patients with Acute Ischemic Stroke: A Predictive Model Using Combined MR Perfusion Biomarkers. ISC. 2015. Nashville (USA).
Voir

Use of DSC-MRI in Differentiating Between True Progression and Pseudo-Progression in Patients with Glioblastoma.

Withey S. B, Davies NP, Flintham RB, Herbert J, Sanghera P, Benghiat H, Cruickshank G, Sawlani V. Use of DSC-MRI in Differentiating Between True Progression and Pseudo-Progression in Patients with Glioblastoma. BNOS. 2015. Nottingham (UK).
Voir

Dynamic Contrast Enhanced MRI For Carotid Space Paraganglioma and Schwannoma.

Gaddikeri S, Anzai Y. Dynamic Contrast Enhanced MRI For Carotid Space Paraganglioma and Schwannoma. ASNR. 2015 Chicago (USA).
Voir

Measurement of Blood-Brain Barrier Permeability: Comparison of Delayed Phase Versus First Pass Using a Two Compartment Model.

Vagal A, Dunning A, Mir D, Sanelli P. Measurement of Blood-Brain Barrier Permeability: Comparison of Delayed Phase Versus First Pass Using a Two Compartment Model. ASNR. 2014. Montreal (Canada).
Voir

Comparison of Quantitative versus Qualitative Evaluation of MR Perfusion Images in Acute Stroke.

Bajaj M, Vaughn L, Moritani T, Capizzano A. Comparison of Quantitative versus Qualitative Evaluation of MR Perfusion Images in Acute Stroke. ASNR. 2014. Montreal (Canada).
Voir

Bias and Precision of Three Different DCE-MRI Analysis Software Packages: A Comparison Using Simulated Data.

Cron GO, Sourbron S, Barboriak DP, Abdeen R, Hogan M, Nguyen TB. Bias and Precision of Three Different DCE-MRI Analysis Software Packages: A Comparison Using Simulated Data. ISMRM. 2014. Milan (Italy).
Voir

IRM de perfusion des tumeurs de l'oropharynx : différenciation p16+/p16 - imagerie fonctionnelle.

Gaultier AL, Espinoza S, Lacan-Melki A, Khettab I, Cuenod C.A, Siauve N, Badoual C, Halimi P. IRM de perfusion des tumeurs de l'oropharynx : différenciation p16+/p16 - imagerie fonctionnelle. JFR. 2014. Paris (France). 
Voir

Functional Imaging for Follow up of Brain Gliomas: Comparison between Dynamic Susceptibility Contrast Perfusion MR and Methionine Metabolism.

Beltran Marin M, Mathey C, Goldman S, Lefranc F, Sadeghi N. Functional Imaging for Follow up of Brain Gliomas: Comparison between Dynamic Susceptibility Contrast Perfusion MR and Methionine Metabolism. ASNR. 2014. Montreal (Canada). 
Voir

Feasibility of Perfusion Fraction from Intravoxel Incoherent Motion as a Biomarker in Contrast-Enhanced Tumor: A Pilot Study in Glioblastoma Patients.

Puig J, Sanchez-Gonzalez J, Blasco G, Daunis-i-Estadella J, Essig M, Jain R, Pedraza S. Feasibility of Perfusion Fraction from Intravoxel Incoherent Motion as a Biomarker in Contrast-Enhanced Tumor: A Pilot Study in Glioblastoma Patients. ASNR. 2014. Montreal (Canada).
Voir

DIFFUSION AND CONVENTIONAL MR IMAGING GENOMIC BIOMARKER SIGNATURE FOR EGFR MUTATION IDENTIFICATION IN GLIOBLASTOMA. Scientific Meeting and Education Day of the Society for Neuro-Oncology.

Wassal E, Zinn P, Colen R. DIFFUSION AND CONVENTIONAL MR IMAGING GENOMIC BIOMARKER SIGNATURE FOR EGFR MUTATION IDENTIFICATION IN GLIOBLASTOMA. Scientific Meeting and Education Day of the Society for Neuro-Oncology. 2014. Miami (USA). 
Voir

DIFFUSION MR IMAGING GENOMIC FEATURES IDENTIFIES GENOMIC TARGETS INVOLVED ININVASION AND POOR PROGNOSIS. Scientific Meeting and Education Day of the Society for Neuro-Oncology.

Wassal E, Ginu Thomas, Zinn P, Colen R. DIFFUSION MR IMAGING GENOMIC FEATURES IDENTIFIES GENOMIC TARGETS INVOLVED ININVASION AND POOR PROGNOSIS. Scientific Meeting and Education Day of the Society for Neuro-Oncology. 2014. Miami (USA).
Voir

DIFFUSION AND CONVENTIONAL MR IMAGING GENOMIC BIOMARKER SIGNATURE PREDICTS IDH-1 MUTATION IN GLIOBLASTOMA PATIENTS. Scientific Meeting and Education Day of the Society for Neuro-Oncology.

Wassal E, Zinn P, Colen R. DIFFUSION AND CONVENTIONAL MR IMAGING GENOMIC BIOMARKER SIGNATURE PREDICTS IDH-1 MUTATION IN GLIOBLASTOMA PATIENTS. Scientific Meeting and Education Day of the Society for Neuro-Oncology. 2014. Miami (USA).
Voir

Optimizing MR Acquisition Time for Dynamic Pituitary Gland Evaluation Utilizing Radial-VIBE with GRASP Reconstruction.

Rossi Espagnet C, Bangiyev L, Jain R, Block K, Babb J, Fatterpekar G. Optimizing MR Acquisition Time for Dynamic Pituitary Gland Evaluation Utilizing Radial-VIBE with GRASP Reconstruction.ASNR. 2014. Montreal (Canada).
Voir

Novel Permeability Criteria to Assess Function of Morphologically Normal Pituitary Gland in Patients with Central Endocrinologic Disturbances.

Rossi Espagnet C, Bangiyev L, Davis A, Block K, George A, Babb J, Fatterpekar G. Novel Permeability Criteria to Assess Function of Morphologically Normal Pituitary Gland in Patients with Central Endocrinologic Disturbances. ASNR. 2014. Montreal (Canada).
Voir

Diffusion Tensor Imaging Of Cervical Spinal Cord A 3t: Normal Values Of Radial, Axial, Mean Diffusivity And Fractional Anisotropy In Anterior Horn, Dorsal Funiculus And Pyramidal Tract At Each Cervical Level.

Crombé A, Menegon P, Tourdias T, Dousset V. Diffusion Tensor Imaging Of Cervical Spinal Cord A 3t: Normal Values Of Radial, Axial, Mean Diffusivity And Fractional Anisotropy In Anterior Horn, Dorsal Funiculus And Pyramidal Tract At Each Cervical Level. ISMRM. 2014. Milan (Italy).
Voir

Tenseur de diffusion de la moelle cervicale à 3T: valeurs normales des paramètres de diffusivité en population seine.

Crombé A, Ménégon P, Molinier S, De Roquefeuil E, Tourdias T, Dausset V. Tenseur de diffusion de la moelle cervicale à 3T: valeurs normales des paramètres de diffusivité en population seine. JFR. 2014. Paris (France).
Voir

Permeability Imaging of the Pituitary Gland: A Novel Application of Radial-VIBE with GRASP Technique.

Rossi Espagnet C, Bangiyev L, Block K, Babb J, Shepherd T, Fatterpekar G. Permeability Imaging of the Pituitary Gland: A Novel Application of Radial-VIBE with GRASP Technique.ASNR. 2014. Montreal (Canada).
Voir

La variation du TTM et du DSC entre le jour de l'HSA et J5, en CT perfusion, prédit l'ischémie cérébrale retardée à un mois.

Rodriguez-Régent C, Hafsa M, Turc G, Chaibi Y, Sermet A, Devaux B, Trystam D, Godon-Hardy S, Oppenheim C, Naggara O. La variation du TTM et du DSC entre le jour de l'HSA et J5, en CT perfusion, prédit l'ischémie cérébrale retardée à un mois. JFR. 2014. Paris (France).
Voir

Tissue Negative-Transient Ischemic Attack: Is There a Role for MR Perfusion?

Gram R, Kidwell CS, Shroff S, Becker J, Nael K. Tissue Negative-Transient Ischemic Attack: Is There a Role for MR Perfusion? ASNR. 2014. Montreal (Canada).
Voir

CT and MR Perfusion Imaging and Good Outcomes in Endovascular Stroke Treatment.

Liebeskind DS, Scalzo F, Johnson MS, Dávalos A, Bonafé A, Castaño C, Chapot R, Arnold M, Sztajzel R, Liebig T, Goyal M, Besselmann M, Moreno A, Schroth G, Gralla J, Pereira VM, Nogueira RG. CT and MR Perfusion Imaging and Good Outcomes in Endovascular Stroke Treatment. ISC. 2014. San Diego (USA).
Voir

A Six Minute MRI Protocol for Evaluation of Acute Ischemic Stroke: Pushing the Boundaries.

Nael K, Khan R, Choudhary G, Meshksar A, Tay J, Drake K, Kidwell CS, Coull BM. A Six Minute MRI Protocol for Evaluation of Acute Ischemic Stroke: Pushing the Boundaries. ASNR. 2014. Montreal (Canada).
Voir

Fractional Anisotropy Changes of White matter Infarction and Hypoperfusion in Patients with Hyperacute Stroke: A Voxel-based Analysis Using and DSC Perfusion.

Nael K, Lafleur SR, Bernstein A, Coull BM, Kidwell CS, Krupinski EA, Trouard TP. Fractional Anisotropy Changes of White matter Infarction and Hypoperfusion in Patients with Hyperacute Stroke: A Voxel-based Analysis Using and DSC Perfusion. ISMRM. 2014. Milan (Italy).
Voir

Role of Arterial Tissue Delay derived from Bayesian Probabilistic Method to Predict Recanalization in Patients with Acute Stroke: A comparison with Normalized Collateral Flow Index.

Meshksar A, Choudhary G, Khan R, Becker J, Kubal W, Nael K. Role of Arterial Tissue Delay derived from Bayesian Probabilistic Method to Predict Recanalization in Patients with Acute Stroke: A comparison with Normalized Collateral Flow Index. ASNR. 2014. Montreal (Canada).
Voir

Brain Dynamic Susceptibility Contrast (DSC) Perfusion Using a Reduced Contrast-dose at 3.0T: Comparison of Bayesian Method and Circulant Singular Value Deconvolution (cSVD).

Nael K, Mossadeghi B, Khan R, Meshksar A, Kubal W, Krupinski EA, Ellingson B. Brain Dynamic Susceptibility Contrast (DSC) Perfusion Using a Reduced Contrast-dose at 3.0T: Comparison of Bayesian Method and Circulant Singular Value Deconvolution (cSVD). ASNR. 2014. Montreal (Canada).
Voir

Initial Experience: Combination of MR Pharmacokinetic Modeling and FDG Uptake Using Simultaneous Dynamic Contrast Enhanced MRI and PET Imaging.

Margolis NE, Moy L, Pujara AC, Amarosa A, Sigmund EE, Geppert C, Glielmi C, Freed M, Feng L, Otazo R, Melsaether AM, Kim S. Initial Experience: Combination of MR Pharmacokinetic Modeling and FDG Uptake Using Simultaneous Dynamic Contrast Enhanced MRI and PET Imaging. ISMRM. 2014. Milan (Italy).
Voir

Measurement of Blood Brain Barrier Permeability: Comparison of Delayed Phase versus First Pass Using a Distributed Parameters Model.

Vagal A, Dunning A, Mir D, Sanelli P. Measurement of Blood Brain Barrier Permeability: Comparison of Delayed Phase versus First Pass Using a Distributed Parameters Model. ASNR. 2014. Montreal (Canada).
Voir

High-Resolution Mapping of the Collateral Circulation Deficit in Patients with Acute MCA-M1 Occlusion by Bayesian Processing of MR Perfusion-Weighted Images.

Nicoli F, Pautot F, Scalzo F, Saver JL, Mitulescu A, Chaibi Y, Girard N, Salamon N, Liebeskind DS. High-Resolution Mapping of the Collateral Circulation Deficit in Patients with Acute MCA-M1 Occlusion by Bayesian Processing of MR Perfusion-Weighted Images. ESC. 2013. London (UK).
Voir

Correction of CBV perfusion maps from T1 leakage effect allows a better correlation of perfusion DSC MR imaging with histopathologic glioma grading and an estimation of vascular permeability.

Viry F, Galanaud D, Mitulescu A, Chaibi Y, Reina V, Leclercq D, Dormont D. Correction of CBV perfusion maps from T1 leakage effect allows a better correlation of perfusion DSC MR imaging with histopathologic glioma grading and an estimation of vascular permeability. ECR. 2013. Vienna (Austria).
Voir

MRI Blood Pool Contrast Agents: Improved Imaging of Glioblastoma.

Puig J, Blasco G, Chwang WB, Daunis-I-Estadella J, Essig M, Jain R, Pedraza S. MRI Blood Pool Contrast Agents: Improved Imaging of Glioblastoma. ESNR. 2013. Frankfurt (Germany).
Voir

Intravoxel Incoherent Motion MR Imaging in Glioblastoma: Comparison With Dynamic Susceptibility Contrast Enhanced And Impact on Survival Prediction.

Puig J, Sànchez-Gonzàlez J, Blasco G, Daunis-I-Estadella J, Essig M, Jain R, Pedraza S. Intravoxel Incoherent Motion MR Imaging in Glioblastoma: Comparison With Dynamic Susceptibility Contrast Enhanced And Impact on Survival Prediction. ESNR. 2013. Frankfurt (Germany).
Voir

Diffusion Tensor Imaging Indexes Correlate With Conventional MRI For Lumbar Intervertebral Disc Degeneration.

Puig J, Blasco G, Daunis-I-Estadella J, Molina X, Guergue C, Pedraza S. Diffusion Tensor Imaging Indexes Correlate With Conventional MRI For Lumbar Intervertebral Disc Degeneration. ESNR. 2013. Frankfurt (Germany).
Voir

Are Thalamic Aphasia and Neglect Due to Cortical Hypoperfusion? Academy of Aphasia. 2013. Lucerne (Switzerland).

Schein M, Rajani S, Hillis AE. Are Thalamic Aphasia and Neglect Due to Cortical Hypoperfusion? Academy of Aphasia. 2013. Lucerne (Switzerland). ESNR. 2013. Frankfurt (Germany).
Voir

Diffusion Tensor Imaging in Acute Stroke: Clinical Applications from Determining Lesion Age to Predicting Outcome.

Puig J, Blasco G, Daunis-I-Estadella J, Castellanos M, Serena J, Figueras J, Pedraza S. Diffusion Tensor Imaging in Acute Stroke: Clinical Applications from Determining Lesion Age to Predicting Outcome. ESNR. 2013. Frankfurt (Germany).
Voir

Magnetic Resonance PWI-Derived Collateral Flow Index Is a Predictor of MCA-M1 Recanalization After IV Thrombolysis: New Insight Using The Bayesian Method.

Nicoli F, Boutelier T, Pautot F, Girard N. Magnetic Resonance PWI-Derived Collateral Flow Index Is a Predictor of MCA-M1 Recanalization After IV Thrombolysis: New Insight Using The Bayesian Method. ISMRM. 2013. Salt Lake City (USA).
Voir

LA RM di perfusione con software dedicato nello studio delle neoplasie cerebrali: Risultati preliminari.

Zeccolini F, Diano AA, Izzo R, Muto M. LA RM di perfusione con software dedicato nello studio delle neoplasie cerebrali: Risultati preliminari. AINR. 2013. L'Aquila (Italy).
Voir

High-Performance-Delay-Insensitive Bayesian Method for Quantifying Brain Perfusion Parameters : New horizons for CT perfusion.

Nicoli F. High-Performance-Delay-Insensitive Bayesian Method for Quantifying Brain Perfusion Parameters : New horizons for CT perfusion. JFR. 2012. Paris (France).
Voir

CT Perfusion for Acute Ischemic Stroke Patients: Think different and move forward. Using the Delay-Insensitive Bayesian Method for Hemodynamic Parameters Estimation.

Nicoli F. CT Perfusion for Acute Ischemic Stroke Patients: Think different and move forward. Using the Delay-Insensitive Bayesian Method for Hemodynamic Parameters Estimation. JFR. 2012. Paris (France).
Voir

Signal-To-Noise Ratio and Acquisition Duration Explain Erroneous Mean Transit Times in Acute Stroke Computed Tomography Perfusion Imaging.

Pautot F, Kudo K, Boutelier T, Sasaki M. Signal-To-Noise Ratio and Acquisition Duration Explain Erroneous Mean Transit Times in Acute Stroke Computed Tomography Perfusion Imaging. ISC. 2012. New Orleans (USA).
Voir

Quantitative T2* Perfusion Evaluation in the Differential Diagnosis between Recurrence and Pseudo-progression in Patients Affected Glioblastoma Multiforme Treated with Radiotherapy and Temozolamide.

Pugliese S, Romano A, Minniti G, Bozzao A. Quantitative T2* Perfusion Evaluation in the Differential Diagnosis between Recurrence and Pseudo-progression in Patients Affected Glioblastoma Multiforme Treated with Radiotherapy and Temozolamide. ESNR.
Voir

Quantitative T2* Perfusion Evaluation in the Differential Diagnosis between Recurrence and Pseudo-progression in Patients Affected Glioblastoma Multiforme Treated with Radiotherapy and Temozolamide.

Pugliese S, Romano A, Minniti G, Fantozzi LM, Bozzao A. Quantitative T2* Perfusion Evaluation in the Differential Diagnosis between Recurrence and Pseudo-progression in Patients Affected Glioblastoma Multiforme Treated with Radiotherapy and Temozolamide. RSNA. 2012. Chicago (USA). Edinburgh (Scotland).
Voir

Pretreatment MRI Markers May Predict Hemorrhagic Transformation in Patients Treated with IV tPA.

Luby M, Boparai S, Warach S. Pretreatment MRI Markers May Predict Hemorrhagic Transformation in Patients Treated with IV tPA. ISC. 2012. New Orleans (USA).
Voir

Inter-observer and Intra-observer agreement of rCBV values in glial tumours using different proprietary analysis software.

Fallatah S, Krishnan A, Brisson M, Adams M, Golay X, Jäger HF. Inter-observer and Intra-observer agreement of rCBV values in glial tumours using different proprietary analysis software. ESNR. 2012. Edinburgh (Scotland).
Voir

Validation of an MRI Post-Processing Software for the evaluation of microvascularization of brain gliomas.

Viry F, Martin-Duverneuil N, Mokthari K, DiGrandi C, Capelle L, Djeridane F, Chiras J, Galanaud D. Validation of an MRI Post-Processing Software for the evaluation of microvascularization of brain gliomas. RSNA. 2011. Chicago (USA). 
Voir

Does Threshold Based Segmentation of MRI Correlate with Visual Reading of Ischemia and Perfusion Deficit in Acute Scans?

Luby M, Boparai S, Lynch JK, Merino JG, Latour LL, Song SS, Hsia AW, Warach S. Does Threshold Based Segmentation of MRI Correlate with Visual Reading of Ischemia and Perfusion Deficit in Acute Scans? ISC. 2011. Los Angeles, CA (USA).
Voir

Validation of an automated perfusion-diffusion lesion assessment tool.

Steve T, Asdaghi N, Jeerakathil T, Knash M, Hameed B, Beaulieu C, Shuaib A, Butcher K. Validation of an automated perfusion-diffusion lesion assessment tool. ISC. 2011. Los Angeles (USA).
Voir

Results of Intravenous Thrombolysis Using Exclusive MR Imaging Selection: A Series of 420 Acute Ischemic Stroke Patients.

Nicoli F. Results of Intravenous Thrombolysis Using Exclusive MR Imaging Selection: A Series of 420 Acute Ischemic Stroke Patients. ASNR. 2010. Boston (USA).
Voir

Microbubble administration during prolonged 2 MHz TCD improves recanalization and long-term functional outcome in acute stroke patients treated with IV thrombolysis for isolated MCA M1 occlusion.

Nicoli F, Squarcioni C, Grimaud L, Barberet M, Girard N. Microbubble administration during prolonged 2 MHz TCD improves recanalization and long-term functional outcome in acute stroke patients treated with IV thrombolysis for isolated MCA M1 occlusion. ESC. 2010. Barcelona (Spain).
Voir

Results of Intravenous Thrombolysis Using Exclusive MR Imaging Selection: A Series of 420 Acute Ischemic Stroke Patients.

Nicoli F, Squarcioni C, Grimaud L, Souleihet V, Barberet M, Girard N. Results of Intravenous Thrombolysis Using Exclusive MR Imaging Selection: A Series of 420 Acute Ischemic Stroke Patients. WSC. 2010. Seoul (South Korea).
Voir

Review and consensus recommendations on clinical APT-weighted imaging approaches at 3T: Application to brain tumors

Amide proton transfer-weighted (APTw) MR imaging shows promise as a biomarker of brain tumor status. Currently used APTw MRI pulse sequences and protocols vary substantially among different institutes, and there are no agreed-on standards in the imaging community. Therefore, the results acquired from different research centers are difficult to compare, which hampers uniform clinical application and interpretation. This paper reviews current clinical APTw imaging approaches and provides a rationale for optimized APTw brain tumor imaging at 3 T, including specific recommendations for pulse sequences, acquisition protocols, and data processing methods. We expect that these consensus recommendations will become the first broadly accepted guidelines for APTw imaging of brain tumors on 3 T MRI systems from different vendors. This will allow more medical centers to use the same or comparable APTw MRI techniques for the detection, characterization, and monitoring of brain tumors, enabling multi-center trials in larger patient cohorts and, ultimately, routine clinical use.
Voir

Current emerging MRI tools for radionecrosis and pseudoprogression diagnosis

This review aims to cover current MRI techniques for assessing treatment response in brain tumors, with a focus on radio-induced lesions.
Voir

CEST MRI provides amide/amine surrogate biomarkers for treatment-naïve glioma sub-typing

Accurate glioma classification affects patient management and is challenging on non- or low-enhancing gliomas. This study investigated the clinical value of different chemical exchange saturation transfer (CEST) metrics for glioma classification and assessed the diagnostic effect of the presence of abundant fluid in glioma subpopulations.
Voir